D. E. Shaw & Co., Inc. Regeneron Pharmaceuticals, Inc. Put Options Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

Put Options

22 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $5.81 Million - $6.61 Million	7,500 New	7,500 $6.59 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $3.46 Million - $3.76 Million	4,900 Added 18.49%	31,400 $22.7 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $14.3 Million - $18.1 Million	-25,000 Reduced 48.54%	26,500 $18.3 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $2.74 Million - $3.69 Million	5,000 Added 10.75%	51,500 $30.4 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $40.8 Million - $47.9 Million	-68,600 Reduced 59.6%	46,500 $32.5 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $17.7 Million - $21.8 Million	32,500 Added 39.35%	115,100 $72.7 Million
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $9.46 Million - $11.2 Million	-20,000 Reduced 19.49%	82,600 $46.1 Million
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $9.34 Million - $11.5 Million	-20,900 Reduced 16.92%	102,600 $48.5 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $22.9 Million - $29.1 Million	47,800 Added 63.14%	123,500 $59.7 Million
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $5.45 Million - $6.58 Million	-10,000 Reduced 11.67%	75,700 $42.4 Million
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $937,308 - $1.22 Million	-1,900 Reduced 2.17%	85,700 $53.4 Million
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $19.6 Million - $28.9 Million	-58,400 Reduced 40.0%	87,600 $42.8 Million
Q4 2019 Feb 14, 2020	SELL	$274.13 - $376.51 $1.78 Million - $2.45 Million	-6,500 Reduced 4.26%	146,000 $54.8 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $15.5 Million - $18.1 Million	56,700 Added 59.19%	152,500 $42.3 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $16.6 Million - $23 Million	55,500 Added 137.72%	95,800 $30 Million
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $41.7 Million - $49.3 Million	-112,100 Reduced 73.56%	40,300 $16.5 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $906,714 - $1.09 Million	-2,700 Reduced 1.74%	152,400 $56.9 Million
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $2.91 Million - $3.39 Million	8,300 Added 5.65%	155,100 $62.7 Million
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $313,060 - $379,489	-1,100 Reduced 0.74%	146,800 $50.6 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $9.35 Million - $11.7 Million	-29,600 Reduced 16.68%	147,900 $50.9 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $20.8 Million - $27.2 Million	57,900 Added 48.41%	177,500 $66.7 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $51.6 Million - $60.3 Million	119,600	119,600 $53.5 Million

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account